TECH OFFERS

The cement industry faces significant challenges, including durability issues, high CO₂ emissions (up to 8% of global emissions), and costly maintenance, particularly in harsh environments like marine and industrial settings. Infrastructure in such conditions suffers a 20-40% reduction in service life, contributing to over $100 billion in annual global repair costs. Addressing these issues, a nanotechnology platform has been developed to create next-generation green cements. These cements utilize nano-engineering and low-energy geo-engineering, converting waste and low-value materials into sustainable, high-performance solutions.  Products:  Type A: Geopolymeric Mortar for Repair and Protection  Crack repair, surface protection and insulation panels. High compressive strength, 2x lifespan of traditional cement, fire resistant and impermeable to water/chemicals. Type B: Eco-cement Marine ecosystems, precast blocks and reef regeneration. High compressive strength, marine compatible and captures CO2. Both cements are VOC free, recyclable, and suitable for extreme environments. Next-gen developments include lightweight, CO2-capturing, and sensor integrated materials, advancing sustainable construction.  The technology owner is seeking collaboration opportunities with cement manufacturers for co-pilot testing, R&D co-development, or technology licensing partnerships, aiming to revolutionize the cement industry through innovative, sustainable solutions.   The nanotechnology platform uses low-energy geo-engineering processes, primarily at room temperature, incorporating minerals, inorganic chemicals, and nanomaterials as needed as nano-engineered activators and additives. It transforms waste, by-products, and low-value materials into next-generation green cements, combining high performance, durability, cost-effectiveness, and sustainability across diverse conditions, from marine to industrial environments, including those impacted by climate change. The nanotechnology platform provides local and regional solutions for a sustainable and resilient built environment. This offers and enables our partners and customers with innovative green cements and green cement-based products, including adhesives, cements, mortars, fine concrete, blocks, bricks, and panels. These products are sustainable, durable, high-performance, cost-effective, and capable of combining advanced properties and diverse performance characteristics. Concrete Repair: High-performance mortars for repairing cracks and spalling in concrete, extending structural life. Surface Protection: Advanced coatings and solutions for protecting and rejuvenating concrete structures. Thermal Insulation: Panels with low thermal conductivity and high waterproofing for energy-efficient buildings. Marine Applications: Cement-free concrete for coastal protection, reef regeneration, and marine infrastructure. Sustainable Construction: Eco-friendly blocks, bricks, and panels for durable, low-carbon building project. Serviceable Obtainable Market (SOM): $250M in building materials, specialty chemicals, concrete repair, waterproofing, adhesives, and grouts. High-Performance Green Cement: SOM of $50M, emphasizing cost-effective and high-performance solutions. Additional Revenue Stream: From waste generators for recycling or upcycling.  The technology delivers unparalleled sustainability and performance, offering ultra-low CO₂ footprints (60–90% reduction compared to traditional cement) and significantly high recyclability. It transforms waste and industrial by-products into high-performance materials, addressing waste management challenges and supporting a circular economy. The materials are multifunctional, providing structural performance, thermal insulation, CO₂ capture, chemical and water resistance, and Euroclass A1 fire resistance. They cater to a wide range of applications, including adhesives, coatings, and prefabricated panels, suitable for both new construction and repair projects in extreme environments such as marine and industrial settings. Combining cost-effectiveness with superior durability, this technology offers a practical solution for sustainability-focused projects, aligning with global trends and regulatory goals like net-zero emissions. It redefines construction materials by integrating sustainability, multifunctionality, and competitive cost, setting a new industry benchmark. Construction and building materials, green cement, low-carbon and eco friendly solutions Waste Management & Recycling, Industrial Waste Management, Sustainability, Low Carbon Economy

Patients recovering from brain injuries or neurological disorders often experience a plateau in recovery within 6-12 months, even though they haven't fully regained their abilities. Similarly, athletes face stagnation in their performance or increased risk of injury when pushing to new levels. These challenges stem from underlying maladaptive neuro-muscular patterns that are not adequately addressed by conventional methods. This neuro-integrative wearable technology provides a breakthrough solution by giving users an “inside view” of their brain and muscle responses in real-time as they perform tasks. By monitoring these responses, the system helps users to self-correct maladaptive behaviors that are limiting their recovery or performance. This process allows users to break through recovery plateaus or avoid performance stagnation by training both brain and muscle function in unison. Beyond aiding in recovery, this wearable is also suitable for new patients and novice athletes seeking a faster track to recovery or peak performance without relying on traditional trial-and-error methods. The technology can be applied across various populations—children, adults, and the elderly—to help improve recovery from disabilities, enhance learning, boost performance, or even slow down the natural decline in abilities with age. The device is portable, easy to use, and adaptable for a variety of settings including hospitals, schools, nursing homes, and home environments. Its potential applications are expanding, with uses in stress disorder prevention, injury prevention, and improving self-regulation in children and adults with special needs. The tech owner is seeking collaboration with: Rehabilitation facilities offering neurorehabilitation for stroke and brain injury recovery. Sports performance centers aiming to prevent injuries and optimize athlete performance. Educational institutions focused on enhancing cognitive, physical and learning development. Muscle and Brain Signal Capture: Combines EMG channels to capture muscle signals and EEG channels for brain activity, providing a comprehensive view of neuro-muscular function. Real-Time Feedback & Guidance: Offers real-time feedback with an audio-visual interface that helps users adjust and improve their movements during tasks. Quick Setup Brain-Muscle Interface: & Lightweight Design: Equipped with dry sensors for easy, quick setup and lightweight wearables that require minimal adjustments, ensuring comfort and portability. Safety & Approvals: Regulatory approved by the HSA (Singapore) and USFDA, ensuring compliance with global safety standards. Flexible Usage & Remote Support: Designed for use in hospitals, homes, and other settings. It is self-administered or used with minimal supervision, offering remote care capabilities for monitoring progress and adjusting programs as needed. This neuro-integrative wearable technology has a wide range of applications in both medical and performance optimization settings. Its ability to monitor and correct neuro-muscular responses in real-time makes it versatile and effective for various conditions and populations, including: Stroke Rehabilitation: Helps stroke patients regain motor skills, balance, and cognitive functions by retraining brain and muscle coordination. Traumatic Brain Injury (TBI): Assists in recovery by addressing the neuro-muscular dysfunctions that hinder progress, improving both physical and cognitive outcomes. Congenital Brain Injury & Developmental Delay: Supports children and adults born with brain injuries or developmental delays by enhancing learning and functional independence. Learning Disorders: Provides a platform for children and adults with learning disabilities to improve cognitive skills such as reading, writing, and comprehension. Sports Peak Performance & Injury Prevention: Enables athletes to overcome performance plateaus and reduce injury risks by optimizing brain-muscle interactions during training. Parkinson’s Disease: Slows the degeneration of motor functions and enhances cognitive abilities in individuals with Parkinson’s disease by continuously stimulating neuroplasticity. Mild Cognitive Impairment (MCI) in the Elderly: Helps older adults maintain or improve cognitive and motor skills, delaying further decline associated with aging. Additionally, this wearable can be combined with rehabilitation equipment such as robotics, stimulators, treadmills, and sports simulators. By providing an “inside view” of brain and muscle activity during various tasks, it enables precise and personalized rehabilitation protocols. This capability is essential for activities that may not be externally observable, ensuring a more comprehensive approach to recovery and performance enhancement. This neuro-integrative wearable technology offers a different approach by training both the brain and muscles simultaneously, leading to faster and more effective recovery. Accelerated Recovery: By targeting brain-muscle coordination, the device facilitates a 70% improvement in chronic patients within 6-8 weeks, allowing for significant gains in mobility, cognition, and independence compared to their baseline condition. Increased Independence: Patients in early stages of recovery, particularly stroke survivors, can achieve higher levels of independence upon hospital discharge, surpassing the progress typically seen with standard care. Remote Rehabilitation: The wearable enables 80% of neurorehabilitation sessions to be conducted remotely, without the need for a therapist’s physical presence. This flexibility supports continuous therapy in both clinical and home settings. Enhanced Therapist Productivity: By reducing the need for constant supervision, therapists can oversee multiple patients simultaneously, resulting in a 3X improvement in productivity. This technology's ability to deliver highly personalized, real-time neuro-muscular feedback makes it faster, more accessible, and more efficient than conventional rehabilitation methods. Neurorehabilitation, Stroke, Neuroplasticity, Brain Interface, Sports, Occupational Therapy, Physical Therapy, Cognitive Therapy, Peak Performance, Learning Disability Healthcare, Medical Devices

The Malabar snapper (Lutjanus malabricus) is a highly sought-after carnivorous fish species, extensively cultured in Singapore and the Indo-Pacific region. Despite its aquaculture significance, no commercial feeds specifically designed to meet its nutritional requirements are available. Instead, production relies on generic diets, which are not cost-effective nor optimized for Malabar snapper’s growth and well-being. This existing practice not only drives up feed costs but also hampers productivity and increases the species' vulnerability to diseases. To address these challenges, a tailored feed formulation for Malabar snapper has been developed to minimize reliance on fish meal by incorporating cost-effective, locally sourced alternative protein ingredients. This innovative approach is designed to optimize growth performance, enhance nutrient utilization, and strengthen health outcomes in Malabar snapper aquaculture. This specialised feed has been developed to meet the dietary requirements of Malabar Snapper, optimising growth, health, and feed efficiency. The formulation consists of a balanced proportion of proteins, carbohydrates, and oils, supplemented with essential micro-ingredients. A co-rotational twin-screw extruder was used to ensure uniform mixing of the ingredients and dried on a fluidized bed dryer to maintain pellet structure. This advanced processing technology employs precise control over moisture, temperature, and processing speed, ensuring enhanced pellet quality and energy-efficient production. Aquaculture feed producers seeking to eliminate the need for extensive research and development in creating a species-specific feed for Malabar snapper Malabar Snapper farmers in Singapore and Indo-Pacific region Species-Specific Nutrition: Tailored to meet the dietary requirements of Malabar snapper, addressing gaps in existing generic marine fish feeds. Proven Farm-Level Performance: Validated under real farm conditions, demonstrating abilities in reducing production time by 17%; improving feed conversion ratio by 25%; and decreasing feed costs by 27%. Sustainability: Reduced reliance on fish meal by including cost-effective, locally available alternative protein sources. High-Quality Manufacturing: Advanced extrusion and drying processes ensure consistent pellet quality and nutritional value, enhancing feed efficiency.   aquaculture feed, sustainable feed, fish farming, feed optimization Life Sciences, Agriculture & Aquaculture, Sustainability, Sustainable Living, Food Security

Collagen is the body's most abundant protein, making up 25-35% of all proteins. It's a vital component of connective tissues in skin, bones, tendons, ligaments, and cartilage. Primarily composed of amino acids—30% glycine, 20% proline, and 10% hydroxyproline—collagen's unique triple-helix structure delivers exceptional strength, elasticity, and flexibility. It supports skin, nail, and hair health, boosts bone density, reduces osteoporosis risk, and enhances gut health. Common sources of collagen include meat, bone broth, fish, gelatin, and dairy. However, traditional collagen products often rely on animal or marine sources, using harsh chemical extraction methods that risk contamination, pose health hazards, and contribute to environmental destruction through waste and animal cruelty. This plant-based collagen precursor powder offers a clean, functional, sustainable, eco-friendly alternative (no e number ingredients). The formulation is enriched with amino acids, vitamins, and antioxidants, vital for collagen synthesis and stability, supporting muscle structure, and reducing collagen breakdown. Rigorously tested for functionality and safety, it avoids harmful chemicals and animal exploitation, significantly reducing environmental impact. The technology owner seeks to work with the OEMs of FMCG/CPGs to incorporate the functional blend in varied foods. The innovation is a plant-only collagen precursor that enhances the absorption of immune-boosting compounds and promotes collagen synthesis, as evidenced by in-house cell line analysis. It effectively reduces collagen breakdown while being cost-efficient compared to other market options. Uniquely, it is 100% water-soluble, allowing for easy incorporation into food products without altering taste. This comprehensive formulation provides essential amino acids that support the body’s natural collagen production. Fortified with Vitamin C, which catalyses crucial enzymatic processes for collagen metabolism, it also features a plant extract blend rich in antioxidants, silica, and Vitamin C. Silica stimulates fibroblast proliferation and growth factor release (like TNF-α and TGF-β), aiding collagen synthesis. These blends offer anti-photoaging and anti-inflammatory benefits, enhancing wound healing and supporting collagen production. Some studies suggest that liquid collagen may be absorbed more rapidly into the bloodstream than capsules, making this technology a compelling choice for those seeking optimal collagen support. This collagen Precursor Powder can be used in a variety of products -  Confectionery  Sports Beverages   Protein shakes  Energy drinks Bars/Gummies The collagen market was valued at approximately $4.5 billion and was projected to grow at a compound annual growth rate (CAGR) of around 6-8% over the next several years. While smaller, the plant-based collagen market has gained traction rapidly, driven by increasing consumer interest in vegan and sustainable products. Due to rising health consciousness and demand for clean-label ingredients, it is expected to grow at a similar or even higher CAGR. Sustainable and Clean: The functional blend is a 100% plant-based collagen precursor with no E-number ingredients, offering a functional and sustainable solution for collagen synthesis. Proven Efficacy: In-house cell line studies demonstrate a 5-fold increase in collagen levels compared to untreated cells and traditional animal-based products. Enhanced Absorption: The functional blend ensures superior collagen precursor amino acids absorption, effectively supporting muscle structure and reducing breakdown. Rich Nutrient Profile: Enriched with essential amino acids, antioxidants, and Vitamin C, it promotes collagen metabolism and overall skin health. Versatile and Flavorless: 100% water-soluble and without off-taste, the functional blend can be easily incorporated into various foods and beverages, catering to diverse dietary preferences. Regulatory compliance - Ingredients used in the formulation are considered as  GRAS. The ingredients incorporated into the formulations are approved by the regulatory bodies of the following countries: the US, Singapore, Europe, and India^^. A dossier and support can be provided if required for any specific approvals. ^^Internal reports on the ingredient approval will be provided if requested during the advanced stages of the project. Plant-based Collagen, Collagen Alternative, Collagen Precursor, Amino Acids, Antioxidants, Synthesis, Sustainable Collagen, Functional Ingredients Materials, Bio Materials, Healthcare, Pharmaceuticals & Therapeutics, Foods, Ingredients, Sustainability, Sustainable Living

Automation for advanced manufacturing has reached its limits due to human biological limitations as well as the need for repetitive, standardized workflows. Deep learning AI is necessary to automate dynamic, non-standard workflows so as to enable true autonomous manufacturing. The product owner has developed an AI controller capable of connecting to manufacturing equipment non-intrusively, through low-level hardware interfaces (e.g. VGA, HDMI, USB), without any modifications or software installation to the existing system. Inside the controller is a powerful manufacturing AI agent that emulates both human judgment and behaviour, capable of fully autonomizing all operations as well as forecast equipment health. With incremental learning capabilities, it can generate new insights for equipment as well as process optimization. Factories can also use this product for intelligent remote control and monitoring (RCM) through their command-and-control platform. Unlike other command centers, this platform need not be manned by subject domain experts. Instead, only an engineer is required to ensure all AI agents are online.  The technology solution has been piloted and successfully deployed within notable semiconductor manufacturers. The technology owner is seeking collaboration opportunities with other advanced manufacturing industries, such as aerospace or medical devices, looking to leverage on smarter autonomous manufacturing and OEM equipment manufacturers looking to explore leveraging on AI capabilities into their existing and future equipment for a more competitive edge. This product combines advancements in AI, software, and hardware as illustrated below: AI Agent Vision-Driven Intelligent Process Automation: With a much more advanced version of robotic process automation (RPA), it is capable of interpreting highly complex UI from the equipment to make real-time dynamic decisions. Equipment Health Prediction: The product automatically collects and analyzes all forms of data from the equipment – process logs, UI information, etc. – and provides a health indicator. A decreasing trend in the health indicator or any anomaly is flagged as a potential issue to be investigated. Equipment Parameter Optimization: Some machines require tuning to ensure that it is performing at its most efficient state or can run the process consistent with expectation. The Equipment Parameter Optimization will analyze and determine the most optimum values for these tuning parameters, and with its Vision-Driven Process Automation, the AI agent can automate the tuning process of any machine with these parameter values. Hardware Non-intrusive compact form factor that supports all major equipment types (e.g. Windows, Linux, Unix, DOS, Sun Microsystem) Multiple low-level hardware interfaces connection (e.g. VGA, HDMI, USB, PS/2) for easy plug-and-play Communicates with equipment via numerous industrial protocols (e.g. MODBUS, RJ45, TCP, RS485/232) Software Remote control and monitoring (RCM) GUI no-code programmer to automate simple workflows using RPA The technology solution can be used for any manufacturing processes (e.g. advanced or precision engineering) that benefits from the utilisation of AI capabilities. These applications include: Equipment with Repetitive Workflow: This is for machines that have simple operation function, workflow, or user interface. The operator is expected to perform simple, repetitive tasks such as start process, pause process, select recipe, and clear a fixed set of alarm notifications. These operations can be automated using the AI’s RPA capabilities. Equipment with Dynamic or Recipe-Dependent Workflow: Many machines require operators to carry out actions based on information set in their recipes. In this case, RPA may be inefficient as it requires an automated RPA workflow for each recipe, with a new workflow for each new recipe created. This technology is able to automate any complex workflow processes into a RPA with dynamic logic. Equipment using Vision Processes (e.g. lithography, visual defect detection): Using the AI’s smart vision capability, it enables autonomous intervention or further automation to improve the vision process by analysing the deployed vision sensors to improve accuracy and optimise parameters which previously require manual intervention. Equipment that Requires Tuning: Some machines require constant/routine tuning as part of the preventive maintenance or for recipe creation/optimisation. The tuning process require high level of technical expertise and experience to analyse current performance and to tune accordingly. The AI is able to shorten the tuning downtime while eliminating inconsistencies, resulting in an improved and consistent autonomous tuning process. The further need for improving productivity and development of AI functionalities enable industrial automation to take a further step. More advanced AI models can now enable further emulation of human judgement and processes on the production floor, shifting from repetitive industrial automation to true autonomy. With more complex and faster workflow requiring immediate responses, there is industrial shift from slower cloud computing to faster edge computing execution. Lastly, legacy equipment currently deployed can now leverage on AI functionalities to further enhance operational efficiency, resulting in an improvement in Overall Equipment Effectiveness (OEE). The technology solution achieves true autonomy in dynamic workflows with any equipment through simple plug-and-play form factor, using advanced computer vision, insight generation and deep learning. This eliminates the need for expert human judgement and technical expertise required to operate and manage. The non-intrusive hardware uses low-level interfaces for connectivity, avoiding the need for long and complex downtime for equipment modification and software installation. With edge computing and easy integration to downstream and upstream processes, the AI agent is able to coordinate across workflows, optimising operations to occur seamlessly without expert monitoring. Lastly, it provides reliable machine performance insights based on current operational data, focusing on proactive and positive maintenance strategies rather than historical failures. Autonomous Manufacturing, Robotic Process Automation, RPA, Intelligent Process Automation, Remote Control and Monitoring, Process Automation, AI, RCM Infocomm, Artificial Intelligence, Manufacturing, Assembly, Automation & Robotics, Robotics & Automation, Smart Cities

AI has the potential to significantly enhance diagnostic efficiency, allowing healthcare providers to quickly analyze medical images (e.g., X-Ray, MRI, CT, PET) and generate preliminary diagnostics for further review. This is achieved through a comprehensive workflow that involves: 1. Leveraging the deep expertise of medical professionals to accurately annotate medical images, creating a robust training dataset for the AI model. 2. Training computer vision models based on these datasets to achieve target performance levels. 3. Continuously refining these models over time through the incorporation of new data. Traditionally, this process demands a team of engineers to set up and maintain multiple tools, making it resource-intensive and costly. The technology offered here is a no-code, end-to-end platform that revolutionizes this process by enabling healthcare professionals to directly contribute their expertise through an AI-assisted image labeling tool. This tool allows technical teams to collaboratively and efficiently label large datasets with pixel-level accuracy. Model training and fine-tuning can then be managed by a single individual, significantly reducing the time from concept to deployment - from months to weeks - while also cutting costs associated with hiring specialized machine learning engineers. The technology owner has worked with universities, hospitals, and MedTech start-ups to develop unique computer vision solutions in the healthcare space. The technology owner is seeking collaborations with healthcare organizations aiming to harness computer vision to enhance operational efficiency and quality of care. Alongside the platform, professional services are available to support development, customize necessary integrations, and ensure the success of client projects. This platform includes the following key features: Labeling Tools for Medical Scans - Supports 2D and 3D scans (e.g., NifTi, DICOM, MPR) - AI-assisted labeling for masks, keypoints, or volume - Collaborative working environment enabling labeling tasks to be distributed, with gates for management review and tie-breaking scenarios for data that are harder to assess - Importable / exportable major annotation formats, including COCO JSON, LabelMe, PascalVOC, COCO MASK, and CSV Width-Height AI-Assisted Labeling  Medical datasets are often large and complex. The AI-assisted labeling feature uses advanced contour analysis methods and deep learning to enable precise labeling with minimal user input. Users simply need to identify areas of interest / not of interest, and the platform will automatically generate accurate masks around the targeted regions. General Specifications - HIPPA and SOC II compliant, with ability to deploy on-premise to protect data security - "One-Click Train" for immediate model training leveraging 50+ foundational models - Audit trails to facilitate approvals for medical AI - documenting characteristics like data sets, model parameters, and model performance This platform addresses one of the major challenges faced by researchers, machine learning engineers, and data scientists in healthcare: the tedious and time-consuming task of data labeling. With this automated segmentation algorithms, teams have successfully labeled thousands of medical images in a fraction of the time typically required. Computational Pathology and Medical Imaging Applications: - Disease Detection and Identification (e.g., Tumor Lesions, Fractures, Foreign Objects) from X-Ray, MRI, and other medical imaging technologies - Anomaly Detection in Blood Cell Scans and Pathology Scans This platform enables healthcare teams to label data significantly faster, utilizing an AI-enabled segmentation tool that requires only a few clicks to create pixel-perfect masks. The tool can be used collaboratively, to divide up the workload between medical professionals, with built-in gates for management review. Given the high level of expertise required for medical data labeling, this platform allows professionals such as doctors and researchers to perform this task up to ten times faster. Additional benefits include a minimal learning curve, as the platform does not require mastery of many different tools. Moreover, it supports an end-to-end workflow, allowing teams to quickly transition from labeled images to trained deep-learning models (e.g., FasterRCNN, MaskRCNN, DeepLabV3, YOLO). The platform also supports the generation of labeled files compatible with multiple popular frameworks, streamlining the process of building and deploying powerful AI models in healthcare. Most importantly, all project IP is owned by the client. This allows MedTech companies to protect their core business. For healthcare systems looking to do in-house development, this fundamentally changes the current economics of AI in healthcare. Instead of pay per use, where costs scale with increased usage, the costs are concentrated into development and use of the AI can scale while costs remain relatively flat. AI-Assisted Image Labeling, Medical Images, Computational Pathology, Computer Vision Infocomm, Video/Image Analysis & Computer Vision, Big Data, Data Analytics, Data Mining & Data Visualisation, Healthcare, Telehealth, Medical Software & Imaging, Healthcare ICT

This technology is a neurointerventional procedure, focusing on transradial access for acute ischemic and hemorrhagic stroke treatment. Traditionally, neurointerventions utilize transfemoral access, but this solution leverages the radial artery for access, providing a safer and more comfortable alternative. By reducing complications and shortening recovery times, the transradial approach significantly enhances patient experience.  The transradial access system comprises three components: a radial access sheath, a selective catheter, and a guiding catheter. Each component is designed to work in harmony, ensuring the system’s compatibility and optimal performance. The radial sheath maintains high structural integrity while reducing radial artery spasm and occlusion. The selective catheter offers multiple proprietary tip shapes for improved access to neuro arteries. The guiding catheter combines distal flexibility and proximal stiffness to ensure smooth catheter pushability and trackability, providing surgeons with an efficient and seamless experience. The trans-radial access catheters for neurosurgery are developed for Asian population whom have narrow arteries.  The technology owner is interested in joint R&D projects to co-develop the technology. The neuro transradial access system comprises three core technologies: the radial access sheath, the selective catheter, and the guiding catheter. Radial Access Sheath: Designed with an optimal balance of flexibility and strength to enable precise navigation through the radial artery. Features a low-profile, thin-walled design to minimize radial artery spasm and ensure patient comfort. Coated with a hydrophilic layer to reduce friction, facilitating smoother sheath insertion and advancement. Selective Catheter: Equipped with a proprietary tip shape that enhances access to critical arteries, including the right/left ICA, ECA, and VA. Incorporates a U-shape stiffness for superior anchorage, preventing slippage during procedures and ensuring stability post-subclavian artery access. Guiding Catheter: Optimal balance of distal flexibility and proximal stiffness. Features a multi-layer design: a polymeric outer layer for flexibility, metallic coils and braids in the mid-layer for added structural support, and a high-wear resistance inner layer to ensure smooth catheter movement within the vasculature. Enables superior pushability and trackability during neurointerventions. This technology is designed for use in neurointervention procedures, with potential applications in the following areas: Aspiration Catheter Microcatheter Intermediate Catheter Distal Delivery Catheter This technology offers several advantages over conventional solutions in the neurointerventional space: Shorter Recovery Time: The design of this system reduces procedural complications and promotes faster recovery times, allowing patients to return to their normal activities sooner. Tailored for the Asian Population: The Trans-Radial Access Catheters are specifically designed for the Asian population, accommodating narrower arteries and ensuring safer and more effective neurointerventional access. Complete Neuro Transradial System: A fully integrated system that provides seamless access from the radial artery to the neurovasculature, minimizing procedural complications. Optimized Radial Sheath: Engineered to reduce radial artery spasm and occlusion, improving patient outcomes and comfort. Selective Catheter with Anchoring Mechanism: The catheter’s design prevents slippage during procedures, enhancing stability and precision during treatments. Guiding Catheter Designed for Optimal Pushability and Trackability: this catheter ensures smooth navigation through the vasculature, improving the overall user experience for surgeons. Medical Device, Neurointerventional, Catheters, Transradial Access, Radial Access Sheath, Selective Catheter, Radial Guide Catheter Healthcare, Medical Devices

In the wake of the COVID-19 pandemic, people have developed new expectations for indoor air quality. It is no longer just about ventilation and purification, but also about providing clean and safe air for a healthier environment. Traditional UVC technology (254 nm) has been widely used in HVAC systems and air purifiers to disinfect airborne pathogens. To ensure its effectiveness, sufficient contact time is required, hence it is often used in unoccupied spaces due to safety concerns.  This solution utilises human-safe 222 nm far-UVC technology which has been shown to be able to effectively inactivate airborne pathogens while maintaining safety since it does not penetrate the outer layer of human skin or eyes. This allows for continuous disinfection of air in occupied spaces. By integrating 222 nm far-UVC technology into HVAC system, including air purification, air monitoring and IoT management platforms, the company offers a complete solution for clean and safe air. With integrated capabilities in both R&D and manufacturing, the company can provide tailor-made solutions for different industry applications. They are seeking collaborations with real estate developers, chain restaurant operators and pathogenic air sampling technology experts to further develop and commercialise this solution. Human-safe 222 nm Far-UVC: An effective and direct disinfection technology, 24x7, no downtime   Green Technology: No chemicals, no mercury, and ozone free Air Quality Monitoring: Multiple sensors IAQ control system New Fresh Air System: Does not rely on fresh air ventilation   Smart IoT System: Enable optimisation of air purification effectiveness and energy efficiency  Reduce Carbon Emission:  Green technology, energy saving This solution could be deployed across various industries, including, but not limited to: Commercial/Residential Complexes Hospitals Hotels and Hospitality Educational Institutions F&B and Catering Operators Indoor Recreational Facilities In addition to indoor occupied spaces, the solution is also applicable in sectors such as the food industry, cold chain, and logistics centres, where secondary pollutants are the major sources of contamination. With the ability to achieve higher number of equivalent air changes, the utilisation of far-UVC for air disinfection offers a more cost effective and energy saving solution for indoor air quality control as compared to traditional air purification methods and reliance on ventilation.  222nm, far-uvc, iaq, covid, flu Green Building, Heating, Ventilation & Air-conditioning, Indoor Environment Quality, Sustainability, Sustainable Living

Immune cell activation and expansion for cell therapy is a strictly regulated process. It demands costly and labour-intensive optimization of cell culture conditions. Major limitations of these processes are cell quality and results consistency. Large amounts of expenses were spent on culture conditions, cell characterizations and quality control (QC) with differing culture protocols and recipes in growing CAR-T cells. This technology has established a biomaterial-based artificial cell platform to replace plastic beads, significantly improving cell stimulation performance. The artificial cells uses polysaccharides, lipids, and proteins to mimic live cells, meeting the demand for reproducibility and standardization while being 100% degradable. To address this gap, a modular, all-signals-in-one microbead-based platform has been developed for the next-generation cell therapy R&D and translation. In this delivery platform design, the modular feature allows rapid ‘plug-and-use’ of multiple surface and soluble signals to grow T-cells ex vivo without the need for extensive setup and integration of culture protocols. This platform aims to provide a seamless and straightforward cell culture experience for the industrial and academic research users to discover new types and applications of immune cell therapy. Additionally, the all-signals-in-one synthetic platform mimics the natural antigen presenting cells to activate and expand T-cells on dish, allowing cell manufacturers to ‘mix-and-grow’ immune cells with reduced effort or technical expertise. This aims to improve the cost-effectiveness and scalability of cell therapy manufacturing. The technology provider is seeking collaborations with cell therapy CDMOs/CMOs in licensing and various R&D developments. The artificial cells are a game-changer in cell therapy, offering a sustainable and environmentally friendly alternative to plastic beads. The core of these cells is made of hydrogel, a biodegradable material that mimics the size and texture of live cells. The hydrogel core is treated with special anchors to allow the coating of lipids, recreating the fluid lipid membrane of real cells. The required activation signals are then docked onto this mobile membrane via avidin-biotin interaction, presenting the signals in the most 'natural' way possible. By mimicking cell-cell interactions, the artificial cells provide enhanced quality signals to target cells. The modular design allows for easy customization of surface signals, enabling selective growth of specific cell types. This versatile platform opens doors to discovering and testing new signal pathways and isolating specific cell types. The technology provider now offers a product for T cell activation and expansion, and is developing working prototypes for regulatory T cell and NK cell activation and expansion. The hydrogel-based artificial cells are not only biodegradable but also have the potential for in vivo immunomodulation, paving the way for vaccines for cancers and autoimmune diseases. This technology empowers researchers to grow better cells quicker and discover specific cell subtypes. Cell therapy manufacturers seeking competitive edges in production speed and quality are ideal commercial partners for this innovative and eco-friendly platform. The proprietary microbead-based platform functions as an artificial cell, with its fluidic membrane surface signals presentation and controlled-released soluble signals. The platform application includes but not limited to: Cell therapy manufacturing: Microbeads can be used to support and supplement ex vivo T-cells activation and expansion. Cell-based therapies and regenerative medicine: Microbeads can be engineered to mimic the functions of specific cell types, such as T-cells for immunotherapy, pancreatic cells for diabetes and glial cells for neuron repair. Versatile high-throughput screening platform bridging in-silica signals discovery and in-vitro validation: The ‘plug-and-use’ microbead-based platform feature, together with the versatility avidin-biotin technology and accessibility of commercial biotinylated recombinant proteins and antibodies enable rapid in vitro tests of novel biochemical signals and combinations on cell functions.   Cell therapy is the next pillar of medicine for the treatment of chronic diseases, such as cancer, autoimmune disorders etc.  The cell expansion market was valued at 41.3B USD in 2021 with a CAGR of 12.6%. Nonetheless, many cell therapeutics are still in the discovery and pre-clinical phase. The clinical translation is hampered by suboptimal culture process, unstandardized protocol, limitations of research tools and ex vivo signals delivery platform and high demand of technical expertise. The predominant player in cell expansion and activation market is the magnetic microbeads with emerging alternatives such as antibody tetramers, polymeric nanomatrix, nanosystems with varying shapes/size/stiffness to expand the cell growth tools, facilitate R&D and translational research of cell therapy. This biomaterial-based artificial cell platform revolutionizes cell therapy by providing a sustainable, eco-friendly, and high-performance alternative to current synthetic solutions. Key Advantages: Environmentally Friendly: 100% biodegradable, mitigating the environmental impact of plastic beads. Versatility: Enables the expansion of diverse cell types unserved by current plastic bead-based solutions, such as tumor infiltrating lymphocytes (TILs), natural killer (NK) cells and regulatory T cells. Superior Performance: Up to 2 times faster immune cell expansion compared to state-of-the-art plastic microbeads, with less cell exhaustion. Streamlined Process: Eliminates the need for de-beading, as the hydrogel-based artificial cells degrade at predetermined timepoints. This artificial cell platform empowers researchers and cell therapy manufacturers to: Contribute to a more sustainable and eco-friendly future in cell therapy. Expand diverse immune cells faster and more efficiently. Produce higher quality cells with less exhaustion. Grow challenging cell types, such as NK cells, with the ability to re-stimulate growth. Simplify their processes by eliminating the need for de-beading. Cell and Gene Therapy, Biomaterials, Immune Cell Therapy, Artificial Antigen Presenting Cells, Cell Expansion, Cell Culture, CGT, Advanced Medicinal Products, ATMPs, CAR-T, CAR-NK, Replacing Plastics, Microcarrier Healthcare, Pharmaceuticals & Therapeutics, Life Sciences, Industrial Biotech Methods & Processes, Biotech Research Reagents & Tools